Eisai
4523.T
#2184
Rank
NZ$14.65 B
Marketcap
NZ$51.94
Share price
0.11%
Change (1 day)
3.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$16.82 Billion

According to Eisai's latest financial reports the company's total assets are NZ$16.82 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Eisai - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-03-31NZ$16.31 B6.07%
2024-03-31NZ$15.37 B1.66%
2023-03-31NZ$15.12 B3.05%
2022-03-31NZ$14.67 B4.31%
2021-03-31NZ$14.07 B-15.23%
2020-03-31NZ$16.60 B17.35%
2019-03-31NZ$14.14 B3.74%
2018-03-31NZ$13.63 B3.24%
2017-03-31NZ$13.20 B5.57%
2016-03-31NZ$12.51 B6.1%
2015-03-31NZ$11.79 B8.45%
2014-03-31NZ$10.87 B-13.28%
2013-03-31NZ$12.53 B-15.1%
2012-03-31NZ$14.76 B-10.49%
2011-03-31NZ$16.50 B-0.54%
2010-03-31NZ$16.58 B-19.18%
2009-03-31NZ$20.52 B50.18%
2008-03-31NZ$13.66 B45.39%
2007-03-31NZ$9.40 B-10.31%
2006-03-31NZ$10.48 B21.12%
2005-03-31NZ$8.65 B-2.69%
2004-03-31NZ$8.89 B-1.99%
2003-03-31NZ$9.07 B-4.41%
2002-03-31NZ$9.49 B-13.13%
2001-03-31NZ$10.92 B